Cargando…

Advanced Vaccine Candidates for Lassa Fever

Lassa virus (LASV) is the most prominent human pathogen of the Arenaviridae. The virus is transmitted to humans by a rodent reservoir, Mastomys natalensis, and is capable of causing lethal Lassa Fever (LF). LASV has the highest human impact of any of the viral hemorrhagic fevers (with the exception...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lukashevich, Igor S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509661/ https://www.ncbi.nlm.nih.gov/pubmed/23202493 http://dx.doi.org/10.3390/v4112514

Ejemplares similares

Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1(-/-) Mice
por: Johnson, Dylan M., et al.
Publicado: (2019)

PROSPECTS OF LASSA FEVER CANDIDATE VACCINES
por: Isaac, Ademusire Babatunde, et al.
Publicado: (2022)

Lassa virus diversity and feasibility for universal prophylactic vaccine
por: Lukashevich, Igor S., et al.
Publicado: (2019)

A Promising Candidate for a Lassa Fever Vaccine
Publicado: (2005)

Vaccine platforms for the prevention of Lassa fever
por: Purushotham, Jyothi, et al.
Publicado: (2019)

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022)

Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation
por: Johnson, Dylan M., et al.
Publicado: (2021)

Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate
por: Zapata, Juan Carlos, et al.
Publicado: (2013)

Lassa fever vaccine prospects: identifying immunodominant multi-epitopes as vaccine candidate
por: Nwabueze, Cherechi Omarabia
Publicado: (2023)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
por: Branco, Luis M, et al.
Publicado: (2010)

In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever
por: Baral, Prabin, et al.
Publicado: (2020)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
por: Wang, Meirong, et al.
Publicado: (2021)

Animal Models of Lassa Fever
por: Sattler, Rachel A., et al.
Publicado: (2020)

Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022)

Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines
por: Murphy, Hannah, et al.
Publicado: (2022)

Current research for a vaccine against Lassa hemorrhagic fever virus
por: Warner, Bryce M, et al.
Publicado: (2018)

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development
por: Hallam, Hoai J., et al.
Publicado: (2018)

An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
por: Zapata, Juan C, et al.
Publicado: (2013)

Development of a New Vaccine for the Prevention of Lassa Fever
por: Geisbert, Thomas W, et al.
Publicado: (2005)

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins
por: Wang, Min, et al.
Publicado: (2017)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)

On the Front Lines of Lassa Fever
por: Bausch, Daniel G., et al.
Publicado: (2004)

Sequelae of Lassa Fever: Postviral Cerebellar Ataxia
por: Ezeomah, Chiomah, et al.
Publicado: (2019)

Lassa fever: another threat from West Africa
por: Brosh-Nissimov, Tal
Publicado: (2016)

The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria
por: Opara, Nnennaya U., et al.
Publicado: (2022)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

T Cell-Dependence of Lassa Fever Pathogenesis
por: Flatz, Lukas, et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2003 and 2004
por: Omilabu, Sunday Aremu, et al.
Publicado: (2005)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2005–2008
por: Ehichioya, Deborah U., et al.
Publicado: (2010)

Laboratory Diagnosis of Lassa Fever, Liberia
por: Panning, Marcus, et al.
Publicado: (2010)

Lassa fever and global health security
por: The Lancet Infectious Diseases
Publicado: (2018)

Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria
por: Ugwu, Chinedu, et al.
Publicado: (2022)

The niche of One Health approaches in Lassa fever surveillance and control
por: Arruda, Liã Bárbara, et al.
Publicado: (2021)

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
por: Günther, S, et al.
Publicado: (2000)

Lassa fever in pregnancy: a systematic review and meta-analysis
por: Kayem, Nzelle D, et al.
Publicado: (2020)

Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development
por: Ibukun, Francis Ifedayo
Publicado: (2020)

Risk Maps of Lassa Fever in West Africa
por: Fichet-Calvet, Elisabeth, et al.
Publicado: (2009)

Mastomys natalensis and Lassa Fever, West Africa
por: Lecompte, Emilie, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5mmpji3chb6j6lkhomncl4oftd